Partners

In 2024, SAFE-ID receives unrestricted educational grants for the annual programme from the following partners:

 

Founding partner

 

GlaxoSmithKline AG

 

Associate partner

 

ViiV Healthcare GmbH

 

 




Event partners

 

Financial support 2024

  • GSK: 40'000 CHF
  • ViiV Healthcare: 75'000 CHF
  • Gilead: 50'000 CHF
  • MSD: 50'000 CHF
  • Astra Zeneca: 25'000 CHF
  • Roche Diagnostics: 5'000 CHF
  • Pfizer: 5'000 CHF
  • Menarini: 5'000 CHF

All partners contribute to all educational events organised by SAFE-ID

 

Event Partner AstraZeneca is supporting the Challenge meeting, local meetings in Basel & Bern, all virtual sessions and the Special Session at SSI Annual meeting

Event Partners Pfizer and Roche are supporting the regional symposium in Berne.

Event Partner Menarini is supporting all Virtual Lunch sessions.